跳至主要内容
临床试验/IRCT20121212011738N3
IRCT20121212011738N3招募中3 期

Determining the effect of Montelukast in reducing disease recurrence in patients with moderate to severe ulcerative colitis during the period of gradual reduction of glucocorticoid dose.

Tabriz University of Medical Sciences0 个研究点目标入组 160 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 75 years(—)
性别
All

入选标准

  • All patients with moderate to severe ulcerative colitis
  • Age 18 to 75 years
  • Involvement beyond the rectosigmoid
  • Treated with a high dose of corticosteroid 40-60 mg daily
  • In the stage of clinical remission
  • Candidate for tapering corticosteroid dose

排除标准

  • Age less than 18
  • Age more than 75
  • Severely ill patients need hospitalization and special measures
  • Pregnant or lactating women
  • Suffering from systemic diseases including heart, kidney, lung or liver failure
  • Patients with impaired level of consciousness
  • patients with Primary sclerosing cholangitis (PSC)
  • patients with eosinophilic colitis
  • patients with psychological diseases
  • patients receiving anti-TNF drugs or cyclosporine

研究者

相似试验